Literature DB >> 23760283

The cyclic GMP-dependent protein kinase Iα suppresses kidney fibrosis.

Elisabeth Schinner1, Andrea Schramm, Frieder Kees, Franz Hofmann, Jens Schlossmann.   

Abstract

Cyclic guanosine monophosphate (cGMP) is synthesized by nitric oxide or natriuretic peptide-stimulated guanylyl cyclases and exhibits pleiotropic regulatory functions in the kidney. Hence, integration of cGMP signaling by cGMP-dependent protein kinases (cGKs) might play a critical role in renal physiology; however, detailed renal localization of cGKs is still lacking. Here, we performed an immunohistochemical analysis of cGKIα and cGKIβ isozymes in the mouse kidney and found both in arterioles, the mesangium, and within the cortical interstitium. In contrast to cGKIα, the β-isoform was not detected in the juxtaglomerular apparatus or medullary fibroblasts. Since interstitial fibroblasts play a prominent role in interstitial fibrosis, we focused our study on cGKI function in the interstitium, emphasizing a functional differentiation of both isoforms, and determined whether cGKIs influence renal fibrosis induced by unilateral ureter obstruction. Treatment with the guanylyl cyclase activators YC1 or isosorbide dinitrate showed stronger antifibrotic effects in wild-type than in cGKI-knockout or in smooth muscle-cGKIα-rescue mice, which are cGKI deficient in the kidney except in the renal vasculature. Moreover, fibrosis influenced the mRNA and protein expression levels of cGKIα more strongly than cGKIβ. Thus, our results indicate that cGMP, acting primarily through cGKIα, is an important suppressor of kidney fibrosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760283     DOI: 10.1038/ki.2013.219

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Differences in the renal antifibrotic cGMP/cGKI-dependent signaling of serelaxin, zaprinast, and their combination.

Authors:  Veronika Wetzl; Elisabeth Schinner; Frieder Kees; Lothar Faerber; Jens Schlossmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-06-28       Impact factor: 3.000

2.  Empagliflozin, SGLT2 inhibitor, attenuates renal fibrosis in rats exposed to unilateral ureteric obstruction: potential role of klotho expression.

Authors:  Noha A T Abbas; Amal El Salem; Mohammed M Awad
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-08-08       Impact factor: 3.000

3.  Increasing cGMP-dependent protein kinase activity attenuates unilateral ureteral obstruction-induced renal fibrosis.

Authors:  Wenpeng Cui; Hasiyeti Maimaitiyiming; Xinyu Qi; Heather Norman; Qi Zhou; Xiaojun Wang; Jian Fu; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2014-02-26

Review 4.  Cyclic nucleotide signalling in kidney fibrosis.

Authors:  Elisabeth Schinner; Veronika Wetzl; Jens Schlossmann
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

5.  Inhibition of the TGFβ signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis.

Authors:  Elisabeth Schinner; Veronika Wetzl; Andrea Schramm; Frieder Kees; Peter Sandner; Johannes-Peter Stasch; Franz Hofmann; Jens Schlossmann
Journal:  FEBS Open Bio       Date:  2017-03-01       Impact factor: 2.693

Review 6.  Pathophysiological implications of hypoxia in human diseases.

Authors:  Pai-Sheng Chen; Wen-Tai Chiu; Pei-Ling Hsu; Shih-Chieh Lin; I-Chen Peng; Chia-Yih Wang; Shaw-Jenq Tsai
Journal:  J Biomed Sci       Date:  2020-05-11       Impact factor: 8.410

7.  Two isoforms of cyclic GMP-dependent kinase-I exhibit distinct expression patterns in the adult mouse dorsal root ganglion.

Authors:  Hitoshi Uchida; Shinji Matsumura; Tayo Katano; Masahiko Watanabe; Jens Schlossmann; Seiji Ito
Journal:  Mol Pain       Date:  2018 Jan-Dec       Impact factor: 3.395

8.  Loss of PKGIβ/IRAG1 Signaling Causes Anemia-Associated Splenomegaly.

Authors:  Michael Majer; Sally Prueschenk; Jens Schlossmann
Journal:  Int J Mol Sci       Date:  2021-05-21       Impact factor: 5.923

9.  Involvement of Cyclic Guanosine Monophosphate-Dependent Protein Kinase I in Renal Antifibrotic Effects of Serelaxin.

Authors:  Veronika Wetzl; Elisabeth Schinner; Frieder Kees; Franz Hofmann; Lothar Faerber; Jens Schlossmann
Journal:  Front Pharmacol       Date:  2016-07-12       Impact factor: 5.810

Review 10.  Particulate Guanylyl Cyclase A/cGMP Signaling Pathway in the Kidney: Physiologic and Therapeutic Indications.

Authors:  Yang Chen; John C Burnett
Journal:  Int J Mol Sci       Date:  2018-03-27       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.